How many stocks are there of Accuray?
The current number of stocks of Accuray is 98.27 M undefined.
Accuray Stocks 2025
Accuray Stocks
98.27 M
Ticker
ARAY
ISIN
US0043971052
WKN
A0MKWM
In 2025, Accuray had 98.27 M outstanding stocks, a 0% change from the 98.27 M stocks in the previous year.
The Accuray Stocks history
| YEAR | NUMBER OF STOCKS (undefined USD) |
|---|---|
| 2027e | 98.27 |
| 2026e | 98.27 |
| 2025e | 98.27 |
| 2024 | 98.27 |
| 2023 | 94.9 |
| 2022 | 92.1 |
| 2021 | 92 |
| 2020 | 90.6 |
| 2019 | 87.5 |
| 2018 | 84.9 |
| 2017 | 82.5 |
| 2016 | 80.5 |
| 2015 | 78.3 |
| 2014 | 75.8 |
| 2013 | 73.3 |
| 2012 | 70.9 |
| 2011 | 60.1 |
| 2010 | 60.2 |
| 2009 | 58.7 |
| 2008 | 60.4 |
| 2007 | 30.8 |
| 2006 | 16 |
| 2005 | 14.3 |
Accuray shares outstanding US0043971052 · A0MKWM
The number of shares was Accuray in 2024 — This indicates how many shares 98.272 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
3 years
5 years
10 years
25 Years
Max
Number of stocks
Details
Revenue, EBIT and Earnings per share
ⓘRevenue Per Share
Revenue per share represents the total revenue Accuray earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.
EBIT Per Share
EBIT per share indicates Accuray's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.
Income Per Share
Income per share, or earnings per share (EPS), reveals the portion of Accuray’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.
Expected Values
Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Accuray's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.
| Number of stocks | |
|---|---|
| 2005 | 14.3 M Aktien |
| 2006 | 16 M Aktien |
| 2007 | 30.8 M Aktien |
| 2008 | 60.4 M Aktien |
| 2009 | 58.7 M Aktien |
| 2010 | 60.2 M Aktien |
| 2011 | 60.1 M Aktien |
| 2012 | 70.9 M Aktien |
| 2013 | 73.3 M Aktien |
| 2014 | 75.8 M Aktien |
| 2015 | 78.3 M Aktien |
| 2016 | 80.5 M Aktien |
| 2017 | 82.5 M Aktien |
| 2018 | 84.9 M Aktien |
| 2019 | 87.5 M Aktien |
| 2020 | 90.6 M Aktien |
| 2021 | 92 M Aktien |
| 2022 | 92.1 M Aktien |
| 2023 | 94.9 M Aktien |
| 2024 | 98.27 M Aktien |
| 2025e | 98.27 M Aktien |
| 2026e | 98.27 M Aktien |
| 2027e | 98.27 M Aktien |
Accuray Aktienanalyse
What does Accuray do?
Accuray Inc is a company that was founded in 1990 and is headquartered in Sunnyvale, California. It is a global leader in providing precision solutions for the radiation treatment of cancer and other medical conditions. The company aims to develop revolutionary technologies that offer doctors and patients new treatment options for cancer and other diseases. History: Accuray was founded as a start-up company by a group of scientists who believed that cancer treatment was a crucial problem, with a lack of precision and control compromising the effectiveness of treatment. Therefore, they decided to develop a solution focused on precise, non-invasive radiation therapy. Since then, Accuray has continuously developed and introduced innovative technologies to enable better treatment for patients. Business model: Accuray's business model focuses on the development, sale, and service of radiation therapy products and solutions. The company provides global clinical support to ensure that customers receive the best possible application of Accuray technologies. Accuray primarily generates its revenues through the sale of radiation therapy systems and services. The company has over 800 employees worldwide and operates manufacturing locations in the US and China. Products and solutions: Accuray offers a wide range of products and solutions for clinical radiation therapy. These include the TomoTherapy systems, CyberKnife systems, and Radixact systems. The TomoTherapy systems have been specifically designed for precise and patient-specific radiation therapy applications. The technology enables precise dosage of radiation to tumor cells, protecting the surrounding healthy tissues. The CyberKnife system is used for the treatment of tumors that are difficult to access, such as those in the brain or spine. The robotic technology and precise radiation dosage enhance the effectiveness of treatment. With the Radixact system, Accuray offers a system that provides the latest generation of radiation therapy. The system delivers extremely precise dosages to the tumor while maximizing the preservation of surrounding tissues. Divisions: Accuray is divided into three business segments: Oncology Systems, Radiation Therapy Services, and Research Solutions. - Oncology Systems: Accuray offers the aforementioned TomoTherapy, CyberKnife, and Radixact systems, providing customers with the latest technology to treat various types of cancer. - Radiation Therapy Services: Accuray also provides a wide range of service and support offerings for its customers. These services include training, maintenance, technician support, and customer support. - Research Solutions: Accuray's research division provides academic institutions and research laboratories with access to a variety of technologies and solutions for radiation therapy and cancer research. Conclusion: Accuray has tirelessly worked to develop innovative technologies for radiation therapy, enabling better treatment and quality of life for patients. The company has made significant progress in recent years and now offers a wide range of products and solutions to its customers. Accuray has established itself as a global leader in radiation therapy and continues its success story with continuous research and innovation. Answer: Accuray Inc is a company that specializes in providing precision solutions for radiation treatment of cancer and other medical conditions. It was founded in 1990 and is headquartered in Sunnyvale, California. The company aims to develop innovative technologies that offer patients and doctors new treatment possibilities. Accuray has three divisions: Oncology Systems, Radiation Therapy Services, and Research Solutions. Their products include TomoTherapy, CyberKnife, and Radixact systems. Accuray is a leading global provider of radiation therapy solutions and continues to make advancements in research and innovation. Accuray ist eines der beliebtesten Unternehmen auf Eulerpool.com.Stocks Details
Evaluating Accuray's Shares Outstanding
Accuray's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.
Year-to-Year Comparison
Tracking the changes in Accuray’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.
Impact on Investments
For investors, understanding Accuray’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.
Interpreting Changes in Shares Outstanding
Variances in Accuray’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.
Frequently Asked Questions about Accuray stock
What does Number of Shares / OutstandingShares mean?
The outstanding shares (or issued shares) of Accuray are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.
How has the number of shares of Accuray evolved in recent years?
The number of shares of Accuray has increased by 0% gestiegen compared to last year.
What does the number of shares mean for investors?
The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.
Why does the number of stocks fluctuate?
There are various factors that can lead to a change. Accuray as a company can issue new shares, carry out stock splits or reverse splits.
Does the number of shares have an impact on the performance of Accuray?
There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
How much dividend does Accuray pay?
Over the past 12 months, Accuray paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Accuray is expected to pay a dividend of 0 USD.
What is the dividend yield of Accuray?
The current dividend yield of Accuray is .
When does Accuray pay dividends?
Accuray pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Accuray?
Accuray paid dividends every year for the past 0 years.
What is the dividend of Accuray?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Accuray located?
Accuray is assigned to the 'Health' sector.
Wann musste ich die Aktien von Accuray kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Accuray from 7/12/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/12/2025.
When did Accuray pay the last dividend?
The last dividend was paid out on 7/12/2025.
What was the dividend of Accuray in the year 2024?
In the year 2024, Accuray distributed 0 USD as dividends.
In which currency does Accuray pay out the dividend?
The dividends of Accuray are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Accuray stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Accuray
Our stock analysis for Accuray Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Accuray Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
